SCHEMBL17295388

SCHEMBL17295388

O=C1C(=Cc2ccc3[nH]cnc3c2)SC(=Nc2ccccc2)N1Cc1ccco1

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.62
▸ MEN1 O00255 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ FNTA P49354 1/20 0.57
▸ FNTB P49356 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ CA9 Q16790 14/20 0.49
▸ CA2 P00918 1/20 0.49
▸ PTPN1 P18031 2/20 0.46
▸ ACP1 P24666 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17302192 1.00 FAAH (0.62) FAAHMEN1LMNAFNTAFNTB
SCHEMBL17295403 0.88 CA9 (0.60) CA9CA2PTPN1ACP1
SCHEMBL17295405 0.88 CA9 (0.60) CA9CA2PTPN1ACP1
SCHEMBL17295572 0.84 FAAH (0.64) FAAHMEN1LMNAFNTAFNTB
SCHEMBL17295570 0.84 FAAH (0.64) FAAHMEN1LMNAFNTAFNTB
SCHEMBL17302245 0.82 FAAH (0.76) FAAHMEN1LMNAFNTAFNTB
SCHEMBL17295376 0.82 FAAH (0.76) FAAHMEN1LMNAFNTAFNTB
SCHEMBL17295631 0.82 LMNA (0.57) FAAHMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL17295632 0.82 LMNA (0.57) FAAHMEN1LMNAKMT2ASMN1; SMN2
SCHEMBL17295441 0.81 LMNA (0.49) FAAHLMNASMN1; SMN2CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback